LAPAROSCOPIC SPLENECTOMY FOR IMMUNE TROMBOCYTOPENIC PURPURA: A SINGLE CENTER EXPERIENCE

Introduction: Since its introduction in the early 1990s, laparoscopic splenectomy (LS) is considered the standard treatment for patients with hematological disorders especially for immune thrombocytopenic purpura (ITP). Although its well-known considered benefits, outcomes may vary depending on a hospital's profile and the experience of the surgeon and center. We would like to present experience of a single center with LS for ITP. Material and Methods: All patients with ITP who underwent LS were included. Several perioperative variables such as age, gender, operating time, blood loss, length of hospital stay, conversion, operation indications were analyzed. Results: In total, 15 patients were included; 7(46.7%) women and 8(53.3%) men, with a median age of 52 (18- 73) years. The median operative time and blood loss were 129 (89-200) min,130 (50-300) ml respectively. The mean time for hospital stay was four days (3- 7 days). Conclusions: Laparoscopic splenectomy is a safe procedure for patients with hematological disorders with a low risk of perioperative complications and mortality.

İMMÜN TROMBOSİTOPENİK PURPURA HASTALARINDA LAPAROSKOPİK SPLENEKTOMİ: TEK MERKEZ DENEYİMİ

Giriş: 1990’lı yılların başlarında yapılmaya başlanan laparoskopik splenektomi (LS) başta immün trombositopenik purpura (ITP) olmak üzere hematolojik hastalıkların tedavisinde standart tedavi olarak kabul edilmiştir. Bilinen birçok faydasına rağmen sonuçları hastane profili, cerrahın tecrübesi ve merkeze bağlı değişkenlik gösterebilmektedir. Bizde ITP nedeniyle yapılan laparoskopik splenektomi deneyimimizi sunmayı amaçladık. Gereç ve Yöntem: LS yapılan ITP’li tüm hastalar dahil edildi. Yaş, cinsiyet, ameliyat süresi, kan kaybı, hastanede kalış süresi,açığa dönme, operasyon indikasyonları gibi çeşitli perioperatif değişkenler analiz edildi. Bulgular: Toplamda 15 hasta alındı; bunların 7’si (%46,7) kadın ve 8’i (%53,3) erkek ve medyan yaşları 52 (18- 73) idi. Medyan operasyon süresi ve kan kaybı sırasıyla 129 (89-200) dk, 130 (50-300) ml idi. Hastanede kalış süresi ortalama dört (3-7)gün idi.

___

Delaitre B, Maignien B. Splenectomy by the laparoscopic approach. Report of a case. Presse Med 1991; 20(44): 2263.

Wang Y, Zhan X, Zhu Y, Xie Z, Zhu J, Ye Z. Laparoscopic splenectomy in portal hypertension: A single-surgeon 13-year experience. Surg Endosc 2010; 24(5): 1164–9.

Park A, Targarona EM, Trias M. Laparoscopic surgery of the spleen: State of the art. Langenbecks Arch Surg 2001; 386(3): 230–9.

Habermalz B, Sauerland S, Decker G,Delaitre B, Gigot JF, Leandros E, et al. Laparoscopic splenectomy: The clinical practice guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2008; 22(4): 821–48.

Pugliese R, Sansonna F, Scandroglio I, Maggioni D, Ferrari GC, Di Lernia S et al. Laparoscopic splenectomy: A retrospective review of 75 cases. Int Surg 2006; 91(2): 82–6.

Terrosu G, Baccarani U, Bresadola V, Sistu MA, Uzzau A, Bresadola F. The impact of splenic weight on laparoscopic splenectomy for splenomegaly. Surg Endosc 2002; 16(1): 103–7.

Boddy AP, Mahon D, Rhodes M. Does open surgery continue to have a role in elective splenectomy? Surg Endosc 2006; 20(7): 1094–8.

Silecchia G, Raparelli L, Casella G, Basso N. Laparoscopic splenectomy for non-traumatic diseases. Minerva Chir 2005; 60(5): 363–74.

Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117(16): 4190—207.

Stasi R, Provan D. Management of immune thrombocytopenic purpura in adults. Mayo Clin Proc 2004; 79(4): 504-22.

Stasi R, Stipa E, Masi M, Cecconi M, Scimò MT, Oliva F, et al. Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. Am J Med 1995; 98(5): 436-42.

Cines DB, Bussel JB. How I treat idiopathic thrombocytopenic purpura (ITP). Blood 2005; 106(7): 2244-51.

Musallam KM, Khalife M, Sfeir PM, Faraj W, Safadi B, Abi Saad GS, et al. Postoperative outcomes after laparoscopic splenectomy compared with open splenectomy. Ann Surg 2013; 257(6); 1116-23.

Huscher CG, Mingoli A, Sgarzini G, Brachini G, Ponzano C, Di Paola M. Laparoscopic treatment of blunt splenic injuries: initial experience with 11 patients. Surg Endosc. 2006; 20(9): 1423–6.

Carbonell AM, Kercher KW, Matthews BD, Joels CS, Sing RF, Heniford BT. Laparoscopic splenectomy for splenic abscess. Surg Laparosc Endosc Percutan Tech 2004; 14(5): 289-91.

Patkowski D, Chrzan R, Wróbel G, Sokół A, Dobaczewski G, Apoznański W, et al. Laparoscopic splenectomy in children: experience in a single institution. J Laparoendosc Adv Surg Tech 2007; 17(2): 230-4.

Patel NY, Chilsen AM, Mathiason MA, Kallies KJ, Bottner WA. Outcomes and complications after splenectomy for hematologic disorders. Am J Surg 2012; 204(6): 1014-9.

Tran T, Demyttenaere SV, Polyhronopoulos G, Seguin C, Artho GP, Kaneva P, et al. Recommended timing for surveillance ultrasonography to diagnose portal splenic vein thrombosis after laparoscopic splenectomy. Surg Endosc 2010; 24(7): 1670-8.

Moris D, Dimitriou N, Griniatsos J. Laparoscopic Splenectomy for Benign Hematological Disorders in Adults: A Systematic Review. In Vivo 2017; 31(3): 291-302.

Vecchio R, Intagliata E, Marchese S, La Corte F, Cacciola RR, Cacciola E. Laparoscopic splenectomy coupled with laparoscopic cholecystectomy. JSLS 2014; 18(2): 252-7.

Brigden ML, Pattullo AL. Prevention and management of overwhelming postsplenectomy infection-an update. Crit Care Med 1999; 27(4): 836-42.

Waghorn DJ. Overwhelming infection in asplenic patients: Current best practice preventive measures are not being followed. J Clin Pathol 2001; 54(3): 214-8.

Gossot D, Fritsch S and Celerier M. Laparoscopic splenectomy: Optimal vascular control using the lateral approach and ultrasonic dissection. Surg Endosc 1999; 13(1): 21-5.

Park A, Gagner M, Pomp A. The lateral approach tolaparoscopic splenectomy. Am J Surg 1997; 173(2): 126-30.

Trias M, Targarona EM, Balague C. Laparoscopic splenectomy: An evolving technique. A comparison between anterior and lateral approaches. Surg Endosc 1996; 10(4): 389-92.

George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88(1): 3-40.

Ojima H, Kato T, Araki K, Okamura K, Manda R, Hirayama I, et al. Factors predicting long term responses to splenectomy in patients with idiopathic thrombocytopenic purpura. World J Surg 2006; 30: 553–9.

Gonzalez-Porras JR, Escalante F, Pardal E, Sierra M, Garcia-Frade LJ, Redondo S, et al. Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia. Eur J Haematol 2103; 91(3): 236-41.

Chen X, Peng B, Cai Y, Zhou J, Wang Y, Wu Z et al. Laparoscopic splenectomy for patients with immune thrombocytopenia and very low platelet count: Is platelet transfusion necessary? J Surg Res 2011; 170(2): e225-32.

Wu Z, Zhou J, Li J, Zhu Y, Peng B. The feasibility of laparoscopic splenectomy for ITP patients without preoperative platelet transfusion. Hepatogastroenterology 2012; 59(113): 81-5.

Zheng CX, Zheng D, Chen LH, Yu JF, Wu ZM. Laparoscopic splenectomy for immune thrombocytopenic purpura at a teaching institution. Chin Med J 2011; 124(8): 1175-80.

Dogan NU, Uysal II, Demirci S, Dogan KH, Kolcu G. Accessory spleens at autopsy. Clin Anat 2011; 24(6): 757-62.

Koshenkov VP, Pahuja AK, Németh ZH, Abkin A, Carter MS. Identification of accessory spleens during laparoscopic splenectomy is superior to preoperative computed tomography for detection of accessory spleens. JSLS 2012; 16(3):387- 91.
İzmir Eğitim ve Araştırma Hastanesi Tıp Dergisi-Cover
  • ISSN: 1305-5151
  • Başlangıç: 1995
  • Yayıncı: İzmir Bozyaka Eğitim ve Araştırma Hastanesi
Sayıdaki Diğer Makaleler

PSÖRİATİK ARTİRİTLİ HASTALARDA TEDAVİ SEÇENEKLERİNİN PSİKİATRİK DURUM VE YAŞAM KALİTESİNE ETKİSİ

Özden YILDIRIM AKAN, Kadir HARMANCI, PINAR ORTAN, İhsan AKAN, Timur PIRILDAR

ZOR ENTÜBASYON KRİTERLERİNİN DEĞERLENDİRİLMESİ: PROSPEKTİF GÖZLEMSEL ÇALIŞMA

Zeki Tuncel TEKGÜL, Murat Yaşar ÖZKALKANLI, Oğuzhan YENİAY, Gizem DEMİR, Sermin KARAARSLAN, Halide Hande ŞAHİNKAYA, Vildan AKPINAR, Erdem YAŞAR

NON-HODGKIN LENFOMA TANILI HASTALARIMIZIN RETROSPEKTİF DEĞERLENDİRİLMESİ

Tuğba ÇETİNTEPE, CELAL ACAR, Şerife SOLMAZ

RENAL HÜCRELİ KANSERDE AST/ALT VE ALBUMİN/GLOBÜLİN ORANININ PROGNOSTİK BELİRTEÇ OLARAK DEĞERLENDİRİLMESİ

İsmail BASMACI, Serdar ÇELİK, Ertuğrul ŞEFİK, M. Erhan AYDIN, İBRAHİM HALİL BOZKURT, BÜLENT GÜNLÜSOY, TANSU DEĞİRMENCİ

LAPAROSCOPIC SPLENECTOMY FOR IMMUNE TROMBOCYTOPENIC PURPURA: A SINGLE CENTER EXPERIENCE

Ozan Bariş NAMDAROĞLU, Savaş YAKAN, Hilmi YAZICI, Sinem NAMDAROĞLU, MEHMET YILDIRIM

ESANSİYEL TROMBOSİTOZ TANILI HASTALARIMIZIN RETROSPEKTİF DEĞERLENDİRİLMESİ

Tuğba ÇETİNTEPE, Lütfi ÇETİNTEPE, Cansu Atmaca MUTLU, Şerife SOLMAZ, CELAL ACAR, Sinem NAMDAROĞLU, Füsun GEDİZ

YÜKSEK RİSKLİ MYELODİSPLASTİK SENDROM TANILI HASTALARIMIZIN RETROSPEKTİF DEĞERLENDİRİLMESİ

Tuğba ÇETİNTEPE, Merve KOÇAR, Lütfi ÇETİNTEPE, Şerife SOLMAZ, CELAL ACAR

ANASTOMOZ KAÇAĞINI SAPTAMAK İÇİN YENİ BİR YÖNTEM: MESANE İÇİ BASINÇ ÖLÇÜMÜ

Özcem ÖFKELİ, Volkan ÖTER, MURAT ULAŞ, Erdal Birol BOSTANCI

DİYABETİK HASTA EĞİTİMİNİN KAN ŞEKERİ REGÜLASYONU VE VÜCUT KİTLE İNDEKSİ ÜZERİNE ETKİNLİĞİNİN DEĞERLENDİRİLMESİ

Özden YILDIRIM AKAN, Ayşen KURTULUŞ, Zübeyde KAYA, ARİF YÜKSEL, PINAR ORTAN, Hasan ALPAY

İMMÜN TROMBOSİTOPENİK PURPURA HASTALARINDA LAPAROSKOPİK SPLENEKTOMİ: TEK MERKEZ DENEYİMİ

Mehmet YILDIRIM, Ozan Barış NAMDAROĞLU, Hilmi YAZICI, Savaş YAKAN, Sinem NAMDAROĞLU